Impaired thermoregulation and beneficial effects of thermoneutrality in the 3xTg-AD model of Alzheimer’s disease (AD)

Abstract The sharp rise in the incidence of Alzheimer’s disease (AD) at an old age coincides with a reduction in energy metabolism and core body temperature. We found that the 3xTg-AD mouse model of AD spontaneously develops a lower basal body temperature and is more vulnerable to a cold environment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurobiology of aging 2016-07
Hauptverfasser: Vandal, Milene, Phillip, White J, Tournissac, Marine, Tremblay, Cyntia, St-Amour, Isabelle, Drouin-Ouellet, Janelle, Bousquet, Melanie, Traversy, Marie-Thérèse, Planel, Emmanuel, Marette, Andre, Calon, Frederic
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract The sharp rise in the incidence of Alzheimer’s disease (AD) at an old age coincides with a reduction in energy metabolism and core body temperature. We found that the 3xTg-AD mouse model of AD spontaneously develops a lower basal body temperature and is more vulnerable to a cold environment compared to age-matched controls. This was despite higher non-shivering thermogenic activity, as evidenced by brown adipose tissue (BAT) norepinephrine content and uncoupling protein 1 (UCP1) expression. A 24-h exposure to cold (4°C) aggravated key neuropathological markers of AD such as: tau phosphorylation, soluble Aβ concentrations and synaptic protein loss in the cortex of 3xTg-AD mice. Strikingly, raising the body temperature of aged 3xTg-AD mice via exposure to a thermoneutral environment improved memory function and reduced amyloid and synaptic pathologies within a week. Our results suggest the presence of a vicious cycle between impaired thermoregulation and AD-like neuropathology and it is proposed that correcting thermoregulatory deficits might be therapeutic in AD.
ISSN:0197-4580
DOI:10.1016/j.neurobiolaging.2016.03.024